What does Bisabolol do?#
A soothing serum with bisabolol, a naturally derived compound found in chamomile, that helps visibly calm redness and supports a more comfortable-looking complexion.
Benefits
- Helps calm the appearance of redness and irritation
- Supports a more comfortable, even-looking skin tone
- Lightweight serum absorbs easily without heaviness
How it works
Bisabolol is a naturally derived compound found in chamomile. It helps skin look calmer and more comfortable, and contributes to a more even-looking skin tone.
How to use Bisabolol#
Before you start
Bisabolol comes from the same plant family as daisies, chamomile, feverfew and arnica. If you already react to any of those, patch test before the first full use.
How often
There is nothing to ease into, and most people have no settling-in period to wait out — a full amount is fine from the first day.
Where it goes
A serum goes on after cleansing and toning, a cream goes on last.
How to apply
Smooth it on rather than rubbing it in.
Sun
Bisabolol isn't one of the actives we flag for extra sun care, so it asks nothing beyond your usual sunscreen — though daily sun protection is what lets the evening-out of tone show at all.
Alongside others
It shares a routine comfortably with everything else on the shelf, exfoliants and retinoids included, so it never needs an evening of its own.
If it doesn't suit
If skin does react, stop rather than push through — a reaction here is unlikely to be a settling-in phase, so don't restart it without checking with a doctor or pharmacist first.
Discontinue use if irritation occurs. Those with chamomile or Compositae/Asteraceae family allergies should patch test first.
Forms you will see it in
Chamomile calming serum
- Where it goes
- Before moisturizer, morning or evening
- How often
- Daily
- Strength
- Gentle
- Sun sensitivity
- None
Chamomile cream
- Where it goes
- As your moisturizer, morning or evening
- How often
- Daily
- Strength
- Gentle
- Sun sensitivity
- None
Using Bisabolol with other ingredients
Pairs well with Bisabolol
Niacinamide
Works well togetherComplementary calming benefits for visibly soothed skin.
Panthenol (B5)
Works well togetherBoth support skin comfort and a healthier-looking complexion.
Allantoin
Works well togetherBoth contribute to a calmer, more comfortable-looking complexion.
What not to use with Bisabolol
Nothing flagged. None of the ingredients this wiki covers needs to be kept apart from Bisabolol — check the label of anything not covered here.
Who should avoid Bisabolol?#
Six situations change whether Bisabolol suits your skin right now. Each one is either a reason to skip it, a reason to go slowly, or nothing to watch for.
- Maternity & Nursing
- Go slowly
- Dry or Itchy Patches
- Go slowly
- Fragile or Sensitive
- No caution
- Recent Facial or Laser
- No caution
- Prone to Redness
- No caution
- Recent Shave or Wax
- No caution
Maternity & Nursing — If you are pregnant or nursing, you may prefer to check with your healthcare provider before use.
Dry or Itchy Patches — Keep the rest of your routine well moisturized, and use it less often — or stop — if you notice tightness or itching.
Cosmetic strength limits for Bisabolol where you live#
| Region | Most a cosmetic may contain | |
|---|---|---|
| No explicit cap | ||
The FDA restricts a short list of ingredients and sets no general strength ceiling on the rest. A figure marked "guidance, not law" is the Cosmetic Ingredient Review panel's recommendation. 21 CFR part 700, subpart B — Requirements for Specific Cosmetic Products (FDA) | ||
| No explicit cap | ||
One list does the work — Health Canada's Hotlist of prohibited and restricted cosmetic ingredients. | ||
| No explicit cap | ||
The Cosmetics Regulation's annexes, consolidated to 1 May 2026. A figure marked "guidance, not law" comes from the EU's cosmetic safety committee rather than from the annexes. | ||
| No explicit cap | ||
Great Britain kept the annexes as its own law and updates them only when it chooses; Northern Ireland follows the live EU Regulation, which is why some rows read differently for each. Regulation (EC) No 1223/2009 as it applies in Great Britain · Regulation (EC) No 1223/2009, Annexes II–VI | ||
| No explicit cap | ||
India writes its own standard, aligned to the European rules as they stood in 2012. Mandatory since 9 February 2026. IS 4707 (Part 2):2025 — restricted and prohibited cosmetic ingredients · IS 4707 (Part 3):2025 — preservatives · Cosmetics Rules, 2020, Ninth Schedule | ||
| No explicit cap | ||
ANVISA rewrote its restricted list in June 2026, and a companion act amended the prohibited list at the same time. RDC 1.029/2026 — restricted ingredients · RDC 529/2021 — prohibited ingredients, as amended by RDC 1.030/2026 · RDC 528/2021 — preservatives | ||
| 1.2% | ||
Japan's cosmetics standard keeps drug ingredients out of cosmetics, so most of its figures sit in the ministry's list of the ones a cosmetic may still contain. Cosmetics Standards (化粧品基準), Ministry of Health, Labour and Welfare · Cosmetics Standards — the ministry's own English translation · Drug ingredients permitted in cosmetics — 2007 notification | ||
| No explicit cap | ||
One MFDS regulation carries both the prohibited list and the restricted list, in force 18 March 2026. Sunscreens and a few other categories are cleared product by product instead. Regulation on Safety Standards for Cosmetics (MFDS Notification 2026-19) · Regulation on the Review of Functional Cosmetics (MFDS Notification 2025-88) | ||
| No explicit cap | ||
Kenya's standard applies the EU annexes as they stand rather than copying them, so its ingredient limits are the EU's — including the 2024 additions. A figure marked "guidance, not law" sits outside the annexes and does not carry over. KS EAS 377-1, -2 and -3:2022 — cosmetics safety requirements, published by KEBS · Regulation (EC) No 1223/2009, Annexes II–VI | ||
| No explicit cap | ||
Namibia sets no ingredient limits at all. Its cosmetic rule is a single line requiring a product to be free of any harmful ingredient. Foodstuffs, Cosmetics and Disinfectants Ordinance 18 of 1979, and the regulations under it | ||
| No explicit cap | ||
Ukraine's own transposition of the EU annexes, as they stood before the 2024 additions, fully in force since 3 August 2026. A further revision is due on 1 February 2027. Technical Regulation on cosmetic products — Cabinet Resolution No. 65 of 20 January 2021 | ||
| No explicit cap | ||
Georgia has no cosmetics rulebook — its register of technical regulations carries no cosmetics entry — so only the general product-safety duty applies. | ||
| No explicit cap | ||
Australia writes no cosmetic ingredient list. A figure here is the point at which a substance becomes a medicine or a scheduled substance carrying Caution labeling, so its numbers sit well above other markets'. Poisons Standard — June 2026 · Therapeutic Goods (Excluded Goods) Determination 2018 | ||
| No explicit cap | ||
The Gulf standard points at the EU annexes as amended, so its ingredient limits are the EU's. A figure marked "guidance, not law" sits outside the annexes and does not carry over. GSO 1943:2024 — Cosmetic products: safety requirements (Gulf technical regulation) · Regulation (EC) No 1223/2009, Annexes II–VI | ||
| No explicit cap | ||
The Gulf standard points at the EU annexes as amended, so its ingredient limits are the EU's. A figure marked "guidance, not law" sits outside the annexes and does not carry over. GSO 1943:2024 — Cosmetic products: safety requirements (Gulf technical regulation) · Regulation (EC) No 1223/2009, Annexes II–VI | ||
| No explicit cap | ||
Hong Kong writes no cosmetics rulebook. Its Poisons List (Cap. 138A, Schedule 10) decides which substances may be sold only as medicines, and general safety is judged case by case against whichever overseas standard the enforcer considers reasonable. Pharmacy and Poisons Regulations (Cap. 138A), Schedule 10 — the poisons list · Pharmacy and Poisons Board — Guidance Notes on classifying pharmaceutical products, April 2026 | ||
| No explicit cap | ||
Singapore writes the ASEAN annexes into its own schedule, and its regulator tells companies to check the current ASEAN release as well — which is why a figure here can read "guidance, not law". Health Products (Cosmetic Products — ASEAN Cosmetic Directive) Regulations 2007, Third Schedule · ASEAN Cosmetic Directive annexes — release 2026-1, 22 June 2026 | ||
| No explicit cap | ||
Brunei carries the 2007 ASEAN annexes in its own schedule and has not updated them since, so it reads differently from Singapore on several ingredients. Medicines (Cosmetic Products) Regulations (Cap. 285 Rg 1), Schedule 1 — revised edition 2024 | ||
| No explicit cap | ||
Jordan's cosmetic rules defer to "the approved references" and name none of them, so there is no Jordanian figure to read. The only number in the instrument governs the ingredient list on the pack. JFDA instructions on cosmetics and pharmaceutical cosmetics, 2026 | ||
| No explicit cap | ||
Trinidad and Tobago has had the power to set cosmetic standards since 1960 and has never used it. The regulations made under the Act cover food and drugs, with no cosmetics part; what binds is the Act's general rule against selling a cosmetic that may injure the user. Food and Drugs Act, Chap. 30:01 · Food and Drugs Regulations | ||
Where a figure appears, that is the maximum strength allowed or advised for bisabolol in that market — some are set in cosmetics regulation, others are the ceiling a cosmetic safety panel recommends. Where no figure appears, the market either sets no cosmetic maximum or handles this ingredient outside its cosmetic rules. These are limits, not targets — the right strength for a formula is the formulator's decision.
Open a market to see the rulebook its figure comes from. Those notes describe each market's own rules as we read them, current to August 24, 2026; the linked documents are the authority, and nothing here is legal advice.
Sample products with Bisabolol#
A few well-known products, not a full list — product names are each brand's own. We don't sell them — the shop prices them in US dollars and ships from Hong Kong, so delivery and duties come on top. It may not ship everywhere.
We may earn a small commission when you buy through these links.
Already have one? Check how it fits your skin with Pick.
Common questions about Bisabolol#
What is Bisabolol?
- The calming part of chamomile, on its own — it softens the look of redness, and over weeks helps even out tone.
What else is Bisabolol called?
- On a label you may see Alpha-bisabolol and Levomenol.
When should you apply Bisabolol?
- Morning or evening.
Which form of Bisabolol should you use?
- Chamomile calming serum — before moisturizer, morning or evening, daily. Chamomile cream — as your moisturizer, morning or evening, daily.
How often can you use Bisabolol?
- Daily.
Where do you apply Bisabolol?
- All over the face. Keep it away from your eyes and lips.
Can you use Bisabolol around the eyes?
- Yes. Bisabolol goes all over the face, the skin around the eyes included — keep it out of your eyes and off your lips.
Does Bisabolol make skin more sensitive to the sun?
- No. Bisabolol is not flagged as increasing sun sensitivity.
What should you not use with Bisabolol?
- Nothing flagged. None of the ingredients this wiki covers needs to be kept apart from Bisabolol — check the label of anything not covered here.
Who should avoid Bisabolol?
- Go slowly with Maternity & Nursing and Dry or Itchy Patches.
Is there a cosmetic limit for Bisabolol?
- No. No cosmetic regulator in the United States, Canada, the European Union or Great Britain sets a maximum strength for it. That is a limit on the rules, not a signal to use more.
Related ingredients#
How we check this#
Everything on this page traces to the sources listed below — regulators' own publications and published studies. Where the evidence does not answer a question, it is left unanswered.
Some sources below are the official product information for prescription medicines, cited for how they interact with this ingredient. We use them for their safety and handling detail only. A cosmetic product is not one of those medicines and is not intended to treat any condition.
Our review is AI-assisted and is not a named expert's opinion. Last reviewed August 7, 2026.
Think something here is out of date or wrong? Email us at wiki@skinintelligence.ai with your reasoning and where you read it. We read what people send, and we update the page when the sources support it.
Regulators and official bodies · 9
- S1Cosmetic Ingredient Review. Safety Assessment of Bisabolol as Used in Cosmetics — Re-Review for Panel Review. Release 20 Feb 2015; Panel meeting 17–18 Mar 2015; prepared by Monice M. Fiume. Includes the 1999 Final Report Summary and Discussion and the 1994–1997 Panel minutes.
- S14Regulation (EU) 2023/1545 amending Regulation (EC) No 1223/2009 as regards labelling of fragrance allergens in cosmetic products. OJ L 188, 27.7.2023. CELEX 32023R1545.
- S15Regulation (EC) No 1223/2009 on cosmetic products, Annexes II and III, as retained in UK law. legislation.gov.uk/eur/2009/1223/annex/II and /annex/III.
- S16Health Canada. Cosmetic Ingredient Hotlist: List of Ingredients that are Prohibited for Use in Cosmetic Products..
- S17US Food and Drug Administration. Prohibited & Restricted Ingredients in Cosmetics..
- S18European Medicines Agency, Committee on Herbal Medicinal Products. European Union herbal monograph on Matricaria recutita L., flos. EMA/HMPC/55843/2011. Chamomile flower preparations, not isolated bisabolol..
- S23Isotretinoin 10 mg soft capsules — Summary of Product Characteristics, §4.4 and §4.5. MHRA-authorised product information via the electronic Medicines Compendium.
- S24Adapalene/Benzoyl Peroxide 0.1%/2.5% gel — Summary of Product Characteristics, §4.4 and §4.5. MHRA-authorised product information via the electronic Medicines Compendium.
- S25Cosmetic Ingredient Review. Safety Assessment of Chamomilla Recutita-Derived Ingredients as Used in Cosmetics (final report, 2014), including Table 1, "Data from CIR Final Safety Assessment on Bisabolol".
Studies and references · 20
- S2Andersen F, Hedegaard K, Petersen TK, Bindslev-Jensen C, Fullerton A, Andersen KE. Anti-irritants I: Dose-response in acute irritation. Contact Dermatitis. 2006;55(3):148–154. PMID 16918613. doi:10.1111/j.1600-0536.2006.00752.x.
- S3Andersen F, Hedegaard K, Petersen TK, Bindslev-Jensen C, Fullerton A, Andersen KE. Anti-irritants II: Efficacy against cumulative irritation. Contact Dermatitis. 2006;55(3):155–159. PMID 16918614. doi:10.1111/j.1600-0536.2006.00756.x.
- S4Ying Y, Fang Y, Chenlan X, Lin S, Jiefang H, Yanan L, Peiwen S. Evaluating the Efficacy of Soothing Agents in Mitigating 0.1% Retinol-Induced Skin Irritation: A Patch Test. J Cosmet Dermatol. 2025;24(10):e70488. PMID 41044804; PMC12494960. doi:10.1111/jocd.70488.
- S5Andersen F, Hedegaard K, Petersen TK, Bindslev-Jensen C, Fullerton A, Andersen KE. The hairless guinea-pig as a model for treatment of cumulative irritation in humans. Skin Res Technol. 2006;12(1):60–67. PMID 16420540. doi:10.1111/j.0909-725X.2006.00133.x.
- S6Andersen F, Hedegaard K, Fullerton A, Petersen TK, Bindslev-Jensen C, Andersen KE. The hairless guinea-pig as a model for treatment of acute irritation in humans. Skin Res Technol. 2006;12(3):183–189. PMID 16827693. doi:10.1111/j.0909-752X.2006.00148.x.
- S7Jacob SE, Matiz C, Herro EM. Compositae-associated allergic contact dermatitis from bisabolol. Dermatitis. 2011;22(2):102–105. PMID 21504695. doi:10.2310/6620.2011.10118.
- S8Russell K, Jacob SE. Bisabolol. Dermatitis. 2010;21(1):57–58. PMID 20137740.
- S9Pastor N, Silvestre JF, Mataix J, Lucas A, Pérez M. Contact cheilitis from bisabolol and polyvinylpyrrolidone/hexadecene copolymer in lipstick. Contact Dermatitis. 2008;58(3):178–179. PMID 18279165. doi:10.1111/j.1600-0536.2007.01225.x.
- S10Hausen BM. A 6-year experience with compositae mix. Am J Contact Dermat. 1996;7(2):94–99. PMID 8796749. doi:10.1016/s1046-199x(96)90081-0.
- S11Paulsen E, Andersen KE, Hausen BM. An 8-year experience with routine SL mix patch testing supplemented with Compositae mix in Denmark. Contact Dermatitis. 2001;45(1):29–35. PMID 11422265. doi:10.1034/j.1600-0536.2001.045001029.x.
- S12Kadir R, Barry BW. α-Bisabolol, a possible safe penetration enhancer for dermal and transdermal therapeutics. Int J Pharm. 1991;70(1–2):87–94. doi:10.1016/0378-5173(91)90167-M — authorship confirmed via Crossref; the ScienceDirect capture held in the vault lists only Barry.
- S13Lee J, Jun H, Jung E, Ha J, Park D. Whitening effect of alpha-bisabolol in Asian women subjects. Int J Cosmet Sci. 2010;32(4):299–303. PMID 20642768. doi:10.1111/j.1468-2494.2010.00560.x.
- S19Bjerring P, Draelos ZD, Fabi SG, Goodman GJ, Hau KC, Haus A, Heydenrych I, Kim J, Lin LC, Sayed K, Sundaram H, Tsubouchi R, Wu Y, Brieva P, Choudhary H, Xiang LF. International Expert Consensus on Integrated Skincare Active Ingredients for Pretreatment and Posttreatment Use With Medical Aesthetic Procedures to Enhance Skin Benefits. J Cosmet Dermatol. 2026;25:e70880. PMID 42087526; PMC13145317. doi:10.1111/jocd.70880.
- S20Nikolis A, Nestor MS, Czuwara J, Depfenhart M, Fluhr JW, Addor FASA, Piotrowski K, Zielinski Y, Lachmann N, Prygova I, Berlin I, Pellacani G. Concomitant Use of Dermo-Cosmetic Skin Care in Aesthetic Procedures: Systematic Review with Expert Panel Recommendations. Clin Cosmet Investig Dermatol. 2026;19. PMID 41773167; PMC12949975. doi:10.2147/CCID.S577128.
- S21Somboon K, Chng CP, Huang C, Gupta S. Enhancing Niacinamide Skin Penetration via Other Skin Brightening Agents: A Molecular Dynamics Simulation Study. Int J Mol Sci. 2025;26(4):1555. PMID 40004021. doi:10.3390/ijms26041555 — in silico.
- S22Maurya AK, Singh M, Singh M, Dubey V, Srivastava S, Luqman S, Bawankule DU. α-(−)-bisabolol reduces pro-inflammatory cytokine production and ameliorates skin inflammation. Curr Pharm Biotechnol. 2014;15(2):173–181. PMID 24894548. doi:10.2174/1389201015666140528152946 — in vitro + mouse.
- S26Vanessa VV, Wan Ahmad Kammal WSL, Lai ZW, How KN. A Review of Moisturizing Additives for Atopic Dermatitis. Cosmetics. 2022;9(4):75. doi:10.3390/cosmetics9040075 — cited only for its Compositae-prevalence secondary reporting; note that this review states bisabolol dermocosmetics "have shown soothing effects" on the strength of multi-ingredient products and does not cite S2S3.
- S27He M, Zhou P, Chen H, Zhang J, Zhang Y, Zheng X, Zhu W, Han L. (−)-α-Bisabolol inhibits D-Gal-induced HSF cellular senescence in vitro and prevents skin aging. Iran J Basic Med Sci. 2024;27(9):1105–1114. PMID 39055870. doi:10.22038/ijbms.2024.76073.16469 — in vitro + mouse.
- S28Licari A, Ruffinazzi G, De Filippo M, Castagnoli R, Marseglia A, Agostinis F, Puviani M, Milani M, Marseglia GL. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial. Minerva Pediatr. 2017;69(6):470–475. PMID 29181960. doi:10.23736/S0026-4946.17.05015-0 — multi-ingredient, uncontrolled.
- S29Varothai S, Chaweekulrat P, Pruksaeakanan C, Wongdama S, Boonchai W. Efficacy of panthenol- and bisabolol-containing lip care as monotherapy for mild-to-moderate cheilitis. Int J Dent Hyg. 2024;22(4):711–716. PMID 37877137. doi:10.1111/idh.12779 — multi-ingredient, open-label, no control.





